Abstract:
Objective To explore the clinical efficacy of Hougu Hewei Granules in the treatment of gastric precancerous lesions, and its effects on serum inflammatory factors and immune function in patients.
Methods A total of 102 patients with gastric precancerous lesions admitted to Guangdong Second Traditional Chinese Medicine Hospital from January 2023 to January 2025 were enrolled and divided into an observation group and a control group by random number table method, with 51 cases in each group. The control group took Weifuchun Tablets orally, while the observation group took Hougu Hewei Granules orally. The course of treatment was 12 weeks for both groups. The total effective rate was compared between the two groups after 12 weeks of treatment. The changes of traditional Chinese medicine (TCM) syndrome scores, levels of inflammatory factors interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α) and immune function indicators (CD3
+, CD4
+ and CD4
+/CD8
+ ratio) were compared between the two groups before treatment, after 4 weeks and 12 weeks of treatment. Adverse reactions during treatment were recorded in both groups.
Results The total effective rate of the observation group was 90.20%, which was higher than that of the control group (74.51%) (
P < 0.05). After 4 weeks and 12 weeks of treatment, the scores of stomach pain, bloating and pain aggravated by pressure, as well as the levels of IL-6, IL- 8 and TNF-α in the two groups were lower than those before treatment, while the percentages of CD3
+ and CD4
+, and the CD4
+/ CD8
+ ratio were higher than those before treatment (
P < 0.05). The TCM syndrome scores and inflammatory factor levels of both groups after 12 weeks of treatment were lower than those after 4 weeks of treatment, and the immune function indicators were higher than those after 4 weeks of treatment (
P < 0.05). After 4 weeks and 12 weeks of treatment, the scores of stomach pain, bloating and pain aggravated by pressure, and the levels of IL-6, IL-8 and TNF- α in the observation group were lower than those in the control group, while the percentages of CD3
+ and CD4
+, and the CD4
+/CD8
+ ratio were higher than those in the control group (
P < 0.05). No adverse reactions occurred in either group during the treatment period.
Conclusion Hougu Hewei Granules has significant therapeutic effect on patients with gastric precancerous lesions. It can effectively improve TCM syndromes, alleviate inflammatory response and regulate immune function, with good value for clinical application and promotion.